This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bashaw, J.
Right arrow Articles by Welkos, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bashaw, J.
Right arrow Articles by Welkos, S.

 Previous Article  |  Next Article 

Clinical and Vaccine Immunology, May 2007, p. 605-616, Vol. 14, No. 5
1071-412X/07/$08.00+0     doi:10.1128/CVI.00398-06
Copyright © 2007, American Society for Microbiology. All Rights Reserved.

Development of In Vitro Correlate Assays of Immunity to Infection with Yersinia pestis{triangledown}

J. Bashaw, S. Norris, S. Weeks, S. Trevino, J. J. Adamovicz, and S. Welkos*

Bacteriology Division, U.S. Army Medical Research Institute of Infectious Diseases, 1425 Porter Street, Fort Detrick, Frederick, Maryland 21702

Received 27 October 2006/ Returned for modification 9 January 2007/ Accepted 7 March 2007

Pneumonic plague is a severe, rapidly progressing disease for which there is no effective vaccine. Since the efficacy of new vaccines cannot be tested in humans, it is essential to develop in vitro surrogate assays that are valid predictors of immunity. The F1 capsule antigen stimulates a protective immune response to most strains of Yersinia pestis. However, strains of Y. pestis that are F1– but still virulent have been isolated, and an in vitro assay, the results which can predict protection against both F1+ and F1– strains, is needed. The virulence antigen (V) is an essential virulence factor of Y. pestis and stimulates protective antibodies. We investigated potential correlates of plague immunity that are based on anti-V antibody-mediated neutralization of Yersinia-induced macrophage cytotoxicity. The neutralizing activity of sera from mice vaccinated with an F1-V fusion candidate vaccine was determined. The decrease in the level of the apoptosis-specific enzyme caspase-3 significantly predicted survival in one- and two-dose vaccination experiments. Sera from F1-V-vaccinated nonhuman primates were evaluated with macrophage assays based on caspase-3 and on other markers manifested at the different stages in cell death. Using murine- and human-derived macrophages in microscopic and fluorescence-activated-cell-sorting-based live/dead staining assays of terminal necrosis, we demonstrated a strong association between in vitro neutralization of macrophage cytotoxicity induced by serum-treated Yersinia and in vivo protection against lethal infection. These results provide a strong base for the development of reliable in vitro correlate bioassays that are predictive of protective immunity to plague.

* Corresponding author. Mailing address: Bacteriology Division, U.S. Army Medical Research Institute of Infectious Diseases, 1425 Porter Street, Fort Detrick, Frederick, MD 21702. Phone: (301) 619-4930. Fax: (301) 619-2152. E-mail: susan.welkos{at}amedd.army.mil

{triangledown} Published ahead of print on 21 March 2007.

Clinical and Vaccine Immunology, May 2007, p. 605-616, Vol. 14, No. 5
1071-412X/07/$08.00+0     doi:10.1128/CVI.00398-06
Copyright © 2007, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Szaba, F. M., Kummer, L. W., Wilhelm, L. B., Lin, J.-S., Parent, M. A., Montminy-Paquette, S. W., Lien, E., Johnson, L. L., Smiley, S. T. (2009). D27-pLpxL, an Avirulent Strain of Yersinia pestis, Primes T Cells That Protect against Pneumonic Plague. Infect. Immun. 77: 4295-4304 [Abstract] [Full Text]  
  • Noel, B. L., Lilo, S., Capurso, D., Hill, J., Bliska, J. B. (2009). Yersinia pestis Can Bypass Protective Antibodies to LcrV and Activation with Gamma Interferon To Survive and Induce Apoptosis in Murine Macrophages. CVI 16: 1457-1466 [Abstract] [Full Text]  
  • Anderson, D. M., Ciletti, N. A., Lee-Lewis, H., Elli, D., Segal, J., DeBord, K. L., Overheim, K. A., Tretiakova, M., Brubaker, R. R., Schneewind, O. (2009). Pneumonic Plague Pathogenesis and Immunity in Brown Norway Rats. Am. J. Pathol. 174: 910-921 [Abstract] [Full Text]  
  • Cornelius, C. A., Quenee, L. E., Overheim, K. A., Koster, F., Brasel, T. L., Elli, D., Ciletti, N. A., Schneewind, O. (2008). Immunization with Recombinant V10 Protects Cynomolgus Macaques from Lethal Pneumonic Plague. Infect. Immun. 76: 5588-5597 [Abstract] [Full Text]  
  • Welkos, S., Norris, S., Adamovicz, J. (2008). Modified Caspase-3 Assay Indicates Correlation of Caspase-3 Activity with Immunity of Nonhuman Primates to Yersinia pestis Infection. CVI 15: 1134-1137 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»